These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25899770)

  • 21. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors.
    Hansmann A; Adolph C; Vogel T; Unger A; Moeslein G
    Cancer; 2004 Feb; 100(3):612-20. PubMed ID: 14745880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment of ileal pouch desmoids using multimodal chemotherapy with low-dose vinblastine and methotrexate in a patient with familial adenomatous polyposis.
    Toiyama Y; Konishi N; Inoue Y; Yoshiyama S; Araki T; Miki C; Kusunoki M
    Clin J Gastroenterol; 2009 Jun; 2(3):170-174. PubMed ID: 26192289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis.
    Azzarelli A; Gronchi A; Bertulli R; Tesoro JD; Baratti D; Pennacchioli E; Dileo P; Rasponi A; Ferrari A; Pilotti S; Casali PG
    Cancer; 2001 Sep; 92(5):1259-64. PubMed ID: 11571741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation-induced Sarcomas Occurring in Desmoid-type Fibromatosis Are Not Always Derived From the Primary Tumor.
    Verschoor AJ; Cleton-Jansen AM; Wijers-Koster P; Coffin CM; Lazar AJ; Nout RA; Rubin BP; Gelderblom H; Bovée JV
    Am J Surg Pathol; 2015 Dec; 39(12):1701-7. PubMed ID: 26414222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review.
    Sakai T; Hamada S; Koike H; Shimizu K; Yoshida M; Nishida Y
    Jpn J Clin Oncol; 2020 Sep; 50(9):1037-1042. PubMed ID: 32533146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?
    Pouessel D; Chevret S; Rolland F; Gravis G; Geoffrois L; Roubaud G; Terrisse S; Boyle H; Chevreau C; Dauba J; Moriceau G; Alexandre I; Deplanque G; Chapelle A; Vauleon E; Colau A; Audenet F; Grellety T; Culine S
    Eur J Cancer; 2016 Feb; 54():69-74. PubMed ID: 26724422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose chemotherapy of desmoid tumors.
    Weiss AJ; Lackman RD
    Cancer; 1989 Sep; 64(6):1192-4. PubMed ID: 2766217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Less-invasive fascia-preserving surgery for abdominal wall desmoid.
    Nishida Y; Hamada S; Sakai T; Ito K; Ikuta K; Urakawa H; Koike H; Imagama S
    Sci Rep; 2021 Sep; 11(1):19379. PubMed ID: 34588532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifocal occurrence of extra-abdominal desmoid type fibromatosis - A rare manifestation. A clinicopathological study of 6 sporadic cases and 1 hereditary case.
    Bekers EM; van Broekhoven DLM; van Dalen T; Bonenkamp JJ; van der Geest ICM; de Rooy JWJ; van Gorp JM; Creytens DH; de Leng WWJ; Scheijen B; Eijkelenboom A; Flucke U
    Ann Diagn Pathol; 2018 Aug; 35():38-41. PubMed ID: 29705714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of CTNNB1 Mutation Status with Progression Arrest Rate in RECIST Progressive Desmoid-Type Fibromatosis Treated with Imatinib: Translational Research Results from a Phase 2 Study of the German Interdisciplinary Sarcoma Group (GISG-01).
    Kasper B; Gruenwald V; Reichardt P; Bauer S; Hohenberger P; Haller F
    Ann Surg Oncol; 2016 Jun; 23(6):1924-7. PubMed ID: 26861905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI.
    Ingley KM; Burtenshaw SM; Theobalds NC; White LM; Blackstein ME; Gladdy RA; Thipphavong S; Gupta AA
    Cancer Med; 2019 Sep; 8(11):5047-5057. PubMed ID: 31301110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study.
    Nathenson MJ; Hu J; Ratan R; Somaiah N; Hsu R; DeMaria PJ; Catoe HW; Pang A; Subhawong TK; Amini B; Sweet K; Feister K; Malik K; Jagannathan J; Braschi-Amirfarzan M; Sheren J; Caldas Y; Moreno Tellez C; Rosenberg AE; Lazar AJ; Maki RG; Benedetto P; Cohen J; Trent JC; Ravi V; Patel S; Wilky BA
    Clin Cancer Res; 2022 Sep; 28(18):4092-4104. PubMed ID: 35180772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sporadic desmoid tumors in the pediatric population: A single center experience and review of the literature.
    Shkalim Zemer V; Toledano H; Kornreich L; Freud E; Atar E; Avigad S; Feinberg-Gorenshtein G; Fichman S; Issakov J; Dujovny T; Yaniv I; Ash S
    J Pediatr Surg; 2017 Oct; 52(10):1637-1641. PubMed ID: 28209418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.
    Colombo C; Miceli R; Lazar AJ; Perrone F; Pollock RE; Le Cesne A; Hartgrink HH; Cleton-Jansen AM; Domont J; Bovée JV; Bonvalot S; Lev D; Gronchi A
    Cancer; 2013 Oct; 119(20):3696-702. PubMed ID: 23913621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis.
    Gega M; Yanagi H; Yoshikawa R; Noda M; Ikeuchi H; Tsukamoto K; Oshima T; Fujiwara Y; Gondo N; Tamura K; Utsunomiya J; Hashimoto-Tamaoki T; Yamamura T
    J Clin Oncol; 2006 Jan; 24(1):102-5. PubMed ID: 16382119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of meloxicam in combination with preoperative chemotherapy for breast cancer - Japan Breast Cancer Research Network (JBCRN) 02-1 trial.
    Yamamoto D; Iwase S; Yoshida H; Kuroda Y; Yamamoto C; Kitamura K; Odagiri H; Nagumo Y
    Anticancer Res; 2011 Oct; 31(10):3567-71. PubMed ID: 21965779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Escalated dosages of methotrexate, vinblastine, doxorubicin, and cisplatin plus recombinant human granulocyte colony-stimulating factor in advanced urothelial carcinoma: an Eastern Cooperative Oncology Group trial.
    Loehrer PJ; Elson P; Dreicer R; Hahn R; Nichols CR; Williams R; Einhorn LH
    J Clin Oncol; 1994 Mar; 12(3):483-8. PubMed ID: 7509853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Metronomic Therapy as a Low-Cost, Sustainable, Standard-of-Care Option in Desmoid Fibromatosis: Real-World Data From a Tertiary Care Center in India.
    Bajpai J; Munot P; Kota K; Gupta G; Gala K; Gulia A; Rekhi B; Khanna N; Shetty N; Bhargava P; Srinivas S; Ostwal V; Patil V; Noronha V; Kulkarni S; Laskar S; Prabhash K; Chinnaswamy G; Gupta S; Banavali S
    JCO Glob Oncol; 2024 May; 10():e2300308. PubMed ID: 38723218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel intra-genic large deletions of CTNNB1 gene identified in WT desmoid-type fibromatosis.
    Colombo C; Urbini M; Astolfi A; Collini P; Indio V; Belfiore A; Paielli N; Perrone F; Tarantino G; Palassini E; Fiore M; Pession A; Stacchiotti S; Pantaleo MA; Gronchi A
    Genes Chromosomes Cancer; 2018 Oct; 57(10):495-503. PubMed ID: 29901254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.